Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 786-794

  Cerutti, Andrea ^a   Schaffer, Andràs ^a,b   Goodwin, Raymond G ^c   Shah, Shefali ^a   Zan, Hong ^a   Ely, Scott ^a   Casali, Paolo ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD40 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 4; INTERLEUKIN 6; KU ANTIGEN; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; M PROTEIN; MONOCLONAL ANTIBODY; PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; DNA RECOMBINATION; GENE SWITCHING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIGAND BINDING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0034661695     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.786     Document Type: Article

References (72)

1. Fujieda, S., K. Zhang, and A. Saxon. 1995. IL-4 plus CD40 monoclonal antibody induces human B cell γ subclass-specific isotype switch: switching to γ1, γ3, and γ4, but not γ2. J. Immunol. 155:2318.
2. + B cell line. J. Immunol. 160:2145.
3. Zan, H., A. Cerutti, A. Schaffer, P. Dramitinos, and P. Casali. 1998. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-β: evidence for TGF-β-dependent but not IL-10-dependent direct Sμ→Sα and sequential Sμ→Sγ, Sγ→Sα DNA recombination. J. Immunol. 162:5217.
4. Van Kooten, C., and J. Banchereau. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1.
5. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity, Annu. Rev. Immunol. 16:111.
6. Kehry, M. R. 1996. CD40-mediated signaling in B cells: balancing cell survival, growth, and death. J. Immunol. 156:2345.
7. Kuhné, M. R., M. Robbins, J. E. Hambor, M. F. Mackey, Y. Kosaka, T. Nishimura, J. P. Gigley, R. J. Noelle, and D. M. Calderhead. 1997. Assembly and regulation of the CD40 receptor complex in human B cells. J. Exp. Med. 186:337.
8. Hostager, B. S., and G. A. Bishop. 1999. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J. Immunol. 162:6307.
9. Leo, E., J. M. Zapata, and J. Reed. 1999. CD40-mediated activation of Ig Cγ1 and Ig Ce germ-line promoters involves multiple TRAF family proteins. Eur. J. Immunol. 29:3908.
10. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Geoddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
11. Pomerantz, J. L., and D. Baltimore. 1999. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18:6694.
12. Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79.
13. Schaffer, A., A. Cerutti, H. Zan, and P. Casali. 1999. The evolutionary conserved sequence upstream of the human Sγ3 region is a functional promoter: synergistic activation by CD40 ligand and IL-4 via distinct cis regulatory elements. J. Immunol. 162:5327.
14. Liu, Y. J., F. Malisan, O. de Bouteiller, C. Guret, S. Lebecque, J. Banchereau, F. C. Mills, E. E. Max, and H. Martinez-Valdez. 1996. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 4:241.
15. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
16. Kelsoe, G. 1996. Life and death in germinal centers (redux). Immunity 4:107.
17. Liu, Y. J., C. Barthelemy, O. de Bouteiller, C. Arpin, I. Durand, and J. Banchereau. 1995. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 2:239.
18. Cerutti, A., A. Schaffer, H. Zan, H.-C. Liou, R. G. Goodwin, and P. Casali. 1998. CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells. Immunity 9:247.
19. Schwarting, R., J. Gerdes, H. Dürkop, B. Falini, S. Pileri, and H. Stein. 1989. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formolresistant epitope. Blood 74:1678.
20. + T cells by IL-4 and IFN-γ. J. Immunol. 158:2090.
21. Gilfillan, M. C., P. J. Noel, E. R. Podack, S. Reiner, and C. B. Thompson. 1998. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. J. Immunol. 160:2180.
22. Del Prete, G., E. Maggi, G. Pizzolo, and S. Romagnani. 1995. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol. Today 16: 76.
23. Horie, R., and T. Watanabe. 1998. CD30: expression and function in health and disease. Semin. Immunol. 10:457.
24. + T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J. Immunol. 164:4399.
25. Cerutti, A., L. Trentin, R. Zambello, R. Sancetta, A. Milani, C. Tassinari, F. Adami, C. Agostini, and G. Semenzato. 1996. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J. Immunol. 157:1854.
26. Gattei, V., M. Degan, A. Gloghini, A. De Iuliis, S. Improta, F. M. Rossi, D. Aldinucci, V. Perin, D. Serraino, R. Babare, et al. 1997. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood 89:2048.
27. + tumors. J. Clin. Oncol. 15:3335.
28. Smith, C. A., H. J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G. R. Sutherland, C. I. Brannan, N. G. Copeland, N. A. Jenkins, et al. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349.
29. + T lymphocytes. J. Immunol. 152:1523.
30. Bowman, M. R., M. A. Crimmins, J. Yetz-Aldape, R. Kriz, K. Kelleher, and S. Hermann. 1994. The cloning of CD70 and its identification as the ligand for CD27. J. Immunol. 152:1756.
31. Pollok, K. E., Y. J. Kim, J. Hurtado, Z. Zhou, K. K. Kim, and B. S. Kwon. 1994. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol. 24:367.
32. Stuber, E., M. Neurath, D. Calderhead, H. P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2:507.
33. Van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced costimulation of T cells in the development of helper function. Nature 378:620.
34. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
35. Brenner, B., U. Koppenhoefer, H. Grassme, J. Kun, F. Lang, and E. Gulbins. 1997. Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett. 417:301.
36. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse. 1997. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159:3838.
37. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123.
38. Langstein, J., J. Michel, J. Fritsche, M. Kreutz, R. Andreesen, and H. Schwarz. 1998. CD137 (1LA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160:2488.
39. Grammer, A. C., R. D. McFarland, J. Heaney, B. F. Darnell, and P. E. Lipsky. 1999. Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J. Immunol. 163:4150.
40. Matsumura, Y., T. Hori, S. Kawamata, A. Imura, and T. Uchiyama. 1999. Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J. Immunol. 163: 3007.
41. (+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med. 191:651.
42. Goodwin, R. G., M. R. Alderson, C. A. Smith, R. J. Armitage, T. VandenBos, R. Jerzy, T. W. Tough, M. A. Schoenbom, T. Davis-Smith, K. Hennen, et al. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73:447.
43. Wiley, S. R., R. G. Goodwin, and C. A. Smith. 1996. Reverse signaling via CD30 ligand. J. Immunol. 157:3635.
44. + B cell line in vitro: definition of the requirements and modalities of hypermutation. J. Immunol. 162:3437.
45. Zan, H., Z. Li, K. Yamaji, P. Dramitinos, A. Cerutti, and P. Casali. 2000. B cell receptor engagement and T cell contact induce bcl-6 somatic hypermutation in human B cells: identity with Ig hypermutation. J. Immunol. 165:830.
46. Meffre, E., F. Papavasiliou, P. Cohen, O. de Bouteiller, D. Bell, H. Karasuyama, C. Schiff, J. Banchereau, Y.-J. Liu, and M. C. Nussenzweig. 1998. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells. J. Exp. Med. 188:765.
47. Pascual, V., Y. J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J. D. Capra. 1994. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180:329.
48. + B cell subset with phenotypical and functional characteristics of germinal center B cells. Eur. J. Immunol. 26:1712.
49. Neurath, M., W. Strober, and Y. Wakatsuki. 1994. The murine Ig 3′ α enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, Sα-BP). J. Immunol. 153:730.
50. Manis, J. P., Y. Gu, R. Lansford, E. Sonoda, R. Ferrini, L. Davidson, K. Rajewsky, and F. W. Alt. 1998. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J. Exp. Med. 187:2081.
51. Casellas, R., A. Nussenzweig, R. Wuerffel, R. Pelanda, A. Reichlin, H. Suh, X.-F. Quin, E. Besmer, A. Kenter, K. Rajewsky, and M. C. Nussenzweig. 1998. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17:2404.
52. Borggrefe, T., M. Wabl, A. T. Akhmedov, and R. Jessberger. 1998. A B-cell-specific DNA recombination complex. J. Biol. Chem. 273:17025.
53. Schrader, C. E., W. Edelmann, R. Kucherlapati, and J. Stavnezer. 1999. Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J. Exp. Med 190:323.
54. Turner, C. A. J., D. H. Mark, and M. M. Davis. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes onto immunoglobulin-secreting cells. Cell 77:297.
55. Huang, S. 1994. Blimp-1 is the murine homolog of the human transcriptional represser PRDI-BF1. Cell 78:9.
56. Jeppson, J. D., H. R. Patel, N. Sakata, J. Domenico, N. Terada, and E. W. Gelfand. 1998. Requirement for dual signals by anti-CD40 and IL-4 for the induction of nuclear factor-KB, IL-6, and IgE in human B lymphocytes. J. Immunol. 161:1738.
57. Neurath, M. F., E. R. Stuber, and W. Strober. 1995. BSAP: a key regulator of B-cell development and differentiation. Immunol. Today 16:564.
58. Flynn, S., K. M. Toellner, C. Raykundalia, M. Goodall, and P. Lane. 1998. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and up-regulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188:297.
59. Del Prete, G., M. De Carli, M. M. D'Elios, K. C. Daniel, F. Almerigogna, M. Alderson, C. A. Smith, E. Thomas, and S. Romagnani. 1995. CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J. Exp. Med. 182:1655.
60. Masat, L., J. Caldwell, R. Armstrong, H. Khoshnevisan, R. Jessberger, B. Herndier, M. Wabl, and D. Ferrick. 2000. Association of SWAP-70 with the B cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 97:2180.
61. Lee, S. Y., A. Reichlin, A. Santana, K. A. Sokol, M. C. Nussenzweig, and Y. Choi. 1997. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7:703.
62. Réigner, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90:373.
63. Horie, R., V. Gattei, K. Ito, S. Imajo-Ohmi, T. Tange, J. Miyauchi, A. Pinto, M. Degan, A. De Iuliis, F. Tassan Mazzocco, et al. 1999. Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms. Am. J. Pathol. 155:2029.
64. Horie, R., K. Ito, M. Tatewaki, M. Nagai, S. Aizawa, M. Higashihara, T. Ishida, J. Inoue, H. Takizawa, and T. Watanabe. 1996. A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages. Blood 88:2422.
65. Usui, T., Y. Wakatsuki, Y. Matsunaga, S. Kaneko, H. Koseki, T. Kita, and H. Kosek. 1997. Overexpression of B cell-specific activator protein (BSAP/ Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. J. Immunol. 158:3197.
66. Skov, S., M. Bonyhadi, N. Odum, and J. A. Ledbetter. 2000. IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells. J. Immunol. 164:3500.
67. Mueller, C. G. F., M. F. Rissoan, B. Salinas, S. Ait-Yahia, O. Ravel, J. M. Bridon, F. Brière, S. Lebecque, and Y. J. Liu. 1997. Polymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cells. J. Exp. Med. 186:655.
68. Yamamoto, S., Y. Higuchi, K. Yoshiyama, E. Shimizu, M. Kataoka, N. Hijiya, and K. Matsuura. 1999. ADAM family proteins in the immune system. Immunol. Today 20:278.
69. Bowen, M. A., K. J. Olsen, L. Cheng, D. Avila, and E. Podack. 1993. Functional effects of CD30 on a large granular lymphoma cell line, YT: inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation. J. Immunol. 151:5896.
70. Kurts, C., F. R. Carbone, M. F. Krummel, K. M. Koch, J. F. Miller, and W. R. Heath. 1999. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 398:341.
71. Heath, W. R., C. Kurts, I. Caminschi, F. R. Carbone, and J. F. Miller. 1999. CD30 prevents T-cell responses to non-lymphoid tissues. Immunol. Rev. 169:23.
72. Piccinni, M. P., M.-G. Giudizi, R. Biagiotti, L. Beloni, L. Giannarini, S. Sampognaro, P. Parronchi, R. Manetti, F. Annunziato, C. Livi, et al. 1995. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 155:128.